We propose that, over time, in the course of type 2 diabetes progression, SCD expression by beta cells is first induced during compensation in response to insulin resistance, and as the duration of diabetes increases, SCD expression decreases leading to a decline in beta cell function. The gene discussed is SCD; the disease is type 2 diabetes mellitus.